$3.3 Million Revenue Successful Full-Service Ophthalmology Practice Based in Southern California

Why It Matters

The acquisition offers a cash‑generating, well‑rated eye‑care platform with clear upside, making it attractive in a market where specialty ophthalmology demand is rising. Its stable payer mix and experienced staff reduce integration risk for buyers seeking immediate earnings and scalable growth.

Key Takeaways

• $3.3M projected revenue with $4.5M asking price.
• Balanced mix: exams, surgeries, in‑office procedures each 25‑50%.
• 4.1‑4.2 star rating indicates strong patient loyalty.
• 15% revenue boost possible via insurance renegotiations.
• Team includes 5 physicians, office manager, 13 support staff.

Pulse Analysis

The Southern California eye‑care market continues to outpace national growth, driven by an aging population and high prevalence of chronic conditions such as glaucoma and macular degeneration. Integrated ophthalmology practices that combine diagnostic, surgical and postoperative services are especially valuable, as they capture the full patient journey and reduce referral leakage. This practice’s dual‑location model, strong online reputation, and established relationships with primary‑care physicians position it well to benefit from regional demographic trends and increasing demand for specialty eye care.

Financially, the practice demonstrates a compelling turnaround narrative. After partners mismanaged expenses, the new leadership restored cost discipline, lifting EBITDA from $204 k in 2024 to $902 k in 2025 while scaling revenue to $2.98 M. The projected 2026 revenue of $3.3 M, paired with a $4.5 M asking price, yields an EBITDA multiple near 5x—competitive for a specialty practice with a proven service mix. Buyers can further enhance margins by optimizing supply contracts and leveraging the existing high‑volume surgical schedule.

Strategic buyers have multiple levers to accelerate growth. Renegotiating insurance contracts could add at least 15% top‑line revenue, while recruiting an additional MD surgeon would expand the surgical pipeline and capture more high‑margin cases. The retained staff, including five physicians and a seasoned office manager, ensures continuity, reducing transition risk. Overall, the practice offers a rare blend of stable cash flow, growth potential, and market positioning that aligns with investors seeking scalable, high‑quality ophthalmology assets.